Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Evaluate the Safety”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02221960
What this trial is testing

Evaluate MEDI6383 Alone and in Combination With MEDI4736 in Adult Subjects With Select Advanced Solid Tumors

Who this might be right for
Recurrent or Metastatic Solid Tumors
MedImmune LLC 39
Not applicableNot Yet RecruitingNCT07645313
What this trial is testing

Accuracy and Safety of Anytime 5Pro and Anytime 4Pro CGM Systems in Adults With Diabetes

Who this might be right for
Diabetes Mellitus, Type 1 | Diabetes Mellitus, Type 2
Yuwell Group 70
Testing effectiveness (Phase 2)Study completedNCT07809282
What this trial is testing

Mitragynine Formulations for Exercise-Induced Muscle Soreness in Healthy Adults

Who this might be right for
Delayed Onset Muscle Soreness (DOMS)Exercise-Induced Muscle Soreness
Traditional Naturals Research Inc. 100
Testing effectiveness (Phase 2)Study completedNCT05626023
What this trial is testing

Human TH-SC01 Cell Injection for Treating Perianal Fistulas in Patients With Crohn's Disease

Who this might be right for
Perianal FistulaCrohn's Disease
Jiangsu Topcel-KH Pharmaceutical Co., Ltd. 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT04515238
What this trial is testing

Sequential Regimen of Bendamustine Followed by Obinutuzumab (GA101), Zanubrutinib (BGB-3111) and Venetoclax (ABT-199) in Patients With Relapsed/Refractory CLL

Who this might be right for
Chronic Lymphoid Leukemia
German CLL Study Group 42
Early research (Phase 1)Ended earlyNCT04033458
What this trial is testing

JNJ-64140284 Solid Dose Formulations in Healthy Male Participants

Who this might be right for
Healthy
Janssen Research & Development, LLC 1
Post-approval studies (Phase 4)Study completedNCT00817648
What this trial is testing

Evaluate the Efficacy and Safety of Seroquel in Chinese Han Patients With Schizophrenia

Who this might be right for
Schizophrenia
Shanghai Mental Health Center 120
Not applicableNot Yet RecruitingNCT06029608
What this trial is testing

Evaluation of the Efficacy and Safety of Magnetically-controlled Capsule Gastroscopy for Postoperative Assessment in Elderly Patients and Patients With Underlying Diseases

Who this might be right for
Evaluation,Efficacy,Safety
Shanghai Jiao Tong University School of Medicine 120
Large-scale testing (Phase 3)Study completedNCT01422876
What this trial is testing

Efficacy and Safety of Empagliflozin (BI 10773) / Linagliptin (BI 1356) Fixed Dose Combination in Treatment naïve and Metformin Treated Type 2 Diabetes Patients

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 1,405
Testing effectiveness (Phase 2)Study completedNCT05734040
What this trial is testing

Immunogenicity and Safety of the Concomitant Administration of OVX836 Influenza Vaccine, Quadrivalent Inactivated Influenza Vaccines and Placebo in Healthy Subjects.

Who this might be right for
Influenza
Osivax 478
Testing effectiveness (Phase 2)Looking for participantsNCT07471789
What this trial is testing

Safety and Efficacy of GYA01 (CART84) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Acute Lymphoblastic T Leukemia Patients (T-ALL).

Who this might be right for
Acute Myeloblastic LeukaemiaLeukemia, T-Cell
Gyala Therapeutics 33
Testing effectiveness (Phase 2)WithdrawnNCT03187691
What this trial is testing

Safety and PK of Oral Encochleated Amphotericin B (CAMB/MAT2203) for Antifungal Prophylaxis in Patients Undergoing Induction Chemotherapy for Acute Myelogenous and Lymphoblastic Leukaemia

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic Leukemia
Matinas BioPharma Nanotechnologies, Inc.
Early research (Phase 1)UnknownNCT04104074
What this trial is testing

Safety and Efficacy of Radiotherapy Plus Sintilimab for HCC With Portal Vein Tumor Thrombosis

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor Thrombosis
Beijing Tsinghua Chang Gung Hospital 20
Not applicableEnded earlyNCT03511716
What this trial is testing

Observational Study of the Heart Repair Technologies Mitral Bridge in Treating Mitral Valve Regurgitation

Who this might be right for
Mitral Regurgitation
Heart Repair Technologies, Inc. 34
Early research (Phase 1)Study completedNCT05439148
What this trial is testing

OPC-61815 in Healthy Chinese Male Subjects

Who this might be right for
Healthy Adult Male
Otsuka Beijing Research Institute 18
Early research (Phase 1)Study completedNCT00425178
What this trial is testing

FGF-1 for Topical Administration for the Treatment of Diabetic or Venous Stasis Ulcers

Who this might be right for
Chronic WoundsDiabetesVenous Stasis Ulcers
Venturis Therapeutics, Inc. 8
Post-approval studies (Phase 4)Study completedNCT00310635
What this trial is testing

Safety, Tolerability and Immunogenicity of Meningococcal C Conjugate Vaccine to Children 32 to 40 Months of Age

Who this might be right for
Meningococcal Infection
Novartis 241
Early research (Phase 1)Study completedNCT01702740
What this trial is testing

The Safety and Pharmacokinetics of CNTO 136 in Patients With Cutaneous Lupus Erythematosus and Systemic Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, CutaneousLupus Erythematosus, Systemic
Centocor Research & Development, Inc. 49
Post-approval studies (Phase 4)Study completedNCT00146068
What this trial is testing

EARLY IFNB-1a and Simvastatin Combination Therapy in Clinically Isolated Syndrome Suggestive of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
University of North Carolina 30
Early research (Phase 1)Study completedNCT00000774
What this trial is testing

A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected Mothers

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 156
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation